Self-injected contraceptives: does the investment reflect women’s preferences?

Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is an innovative contraceptive method aimed at meeting women’s unique circumstances and needs, largely due to its ability to be self-injected. Substantial research and advocacy investments have been made to promote roll-out of DMPA-SC across s...

Full description

Bibliographic Details
Published in:BMJ Global Health
Main Authors: Sophia Magalona, Pierre Akilimali, Philip Anglewicz, Peter Gichangi, Elizabeth Omoluabi, Funmilola OlaOlorun, Georges Guiella, Shannon N. Wood, Linnea A. Zimmerman
Format: Article
Language:English
Published: BMJ Publishing Group 2022-07-01
Online Access:https://gh.bmj.com/content/7/7/e008862.full